IOSP vs. CE, BCPC, NEU, FUL, ASH, SXT, MTX, KWR, SCL, and FTK
Should you be buying Innospec stock or one of its competitors? The main competitors of Innospec include Celanese (CE), Balchem (BCPC), NewMarket (NEU), H.B. Fuller (FUL), Ashland (ASH), Sensient Technologies (SXT), Minerals Technologies (MTX), Quaker Chemical (KWR), Stepan (SCL), and Flotek Industries (FTK). These companies are all part of the "specialty chemicals" industry.
Innospec vs.
Innospec (NASDAQ:IOSP) and Celanese (NYSE:CE) are both mid-cap basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, community ranking, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.
Innospec pays an annual dividend of $1.58 per share and has a dividend yield of 1.4%. Celanese pays an annual dividend of $2.80 per share and has a dividend yield of 3.9%. Innospec pays out 27.6% of its earnings in the form of a dividend. Celanese pays out 28.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Celanese has a consensus target price of $106.00, indicating a potential upside of 45.81%. Given Celanese's stronger consensus rating and higher possible upside, analysts plainly believe Celanese is more favorable than Innospec.
Celanese has a net margin of 10.40% compared to Innospec's net margin of 7.68%. Innospec's return on equity of 13.33% beat Celanese's return on equity.
Celanese received 354 more outperform votes than Innospec when rated by MarketBeat users. However, 66.20% of users gave Innospec an outperform vote while only 62.74% of users gave Celanese an outperform vote.
96.6% of Innospec shares are held by institutional investors. Comparatively, 98.9% of Celanese shares are held by institutional investors. 1.4% of Innospec shares are held by insiders. Comparatively, 0.4% of Celanese shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Celanese has higher revenue and earnings than Innospec. Celanese is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.
In the previous week, Celanese had 28 more articles in the media than Innospec. MarketBeat recorded 30 mentions for Celanese and 2 mentions for Innospec. Innospec's average media sentiment score of 1.77 beat Celanese's score of 0.41 indicating that Innospec is being referred to more favorably in the media.
Innospec has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Celanese has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500.
Summary
Celanese beats Innospec on 12 of the 20 factors compared between the two stocks.
Get Innospec News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Innospec Competitors List
Related Companies and Tools
This page (NASDAQ:IOSP) was last updated on 1/20/2025 by MarketBeat.com Staff
